{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T16:47:04Z","timestamp":1694105224377},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anaesthesist"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00101-013-2197-3","type":"journal-article","created":{"date-parts":[[2013,7,11]],"date-time":"2013-07-11T06:51:05Z","timestamp":1373525465000},"page":"571-582","source":"Crossref","is-referenced-by-count":3,"title":["Hepatorenales Syndrom"],"prefix":"10.1007","volume":"62","author":[{"given":"G.","family":"Huschak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.X.","family":"Kaisers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Laudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,13]]},"reference":[{"key":"2197_CR1","first-page":"570","volume":"55","author":"Helvig","year":"1932","unstructured":"Helvig FC, Schutz CB (1932) A liver and kidney syndrome: clinical, pathological, and experimental studies. Surg Gynecol Obstet 55:570\u2013582","journal-title":"Surg Gynecol Obstet"},{"key":"2197_CR2","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0140-6736(56)90149-0","volume":"271","author":"Hecker","year":"1956","unstructured":"Hecker R, Sherlock S (1956) Electrolyte and circulatory changes in terminal liver failure. Lancet 271:1121\u20131125","journal-title":"Lancet"},{"key":"2197_CR3","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2215\/CJN.01340406","volume":"1","author":"Wadei","year":"2006","unstructured":"Wadei HM, Mai ML, Ahsan N, Gonwa TA (2006) Hepatorenal syndrome: pathophysiology and management. Clin J Am Soc Nephrol 1:1066\u20131079","journal-title":"Clin J Am Soc Nephrol"},{"key":"2197_CR4","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","volume":"362","author":"Gin\u00e8s","year":"2003","unstructured":"Gin\u00e8s P, Guevara M, Arroyo V, Rod\u00e9s J (2003) Hepatorenal syndrome. Lancet 362:1819\u20131827","journal-title":"Lancet"},{"key":"2197_CR5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","volume":"105","author":"Gin\u00e8s","year":"1993","unstructured":"Gin\u00e8s A, Escorsell A, Gin\u00e8s P et al (1993) Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 105:229\u2013236","journal-title":"Gastroenterology"},{"key":"2197_CR6","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","volume":"361","author":"Gin\u00e8s","year":"2009","unstructured":"Gin\u00e8s P, Schrier RW (2009) Renal failure in cirrhosis. N Engl J Med 361:1279\u20131290","journal-title":"N Engl J Med"},{"key":"2197_CR7","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/gut.2006.107789","volume":"84","author":"Salerno","year":"2008","unstructured":"Salerno F, Gerbes A, Gin\u00e8s P et al (2008) Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Postgrad Med J 84:662\u2013670","journal-title":"Postgrad Med J"},{"key":"2197_CR8","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","volume":"41","author":"Alessandria","year":"2005","unstructured":"Alessandria C, Ozdogan O, Guevara M et al (2005) MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology 41:1282\u20131289","journal-title":"Hepatology"},{"key":"2197_CR9","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","volume":"8","author":"Schrier","year":"1988","unstructured":"Schrier RW, Arroyo V, Bernardi M et al (1988) Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8:1151\u20131157","journal-title":"Hepatology"},{"key":"2197_CR10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/0885066611408692","volume":"28","author":"Wadei","year":"2013","unstructured":"Wadei HM, Gonwa TA (2013) Hepatorenal syndrome in the intensive care unit. J Intensive Care Med 28:79\u201392","journal-title":"J Intensive Care Med"},{"key":"2197_CR11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199808203390807","volume":"339","author":"Martin","year":"1998","unstructured":"Martin PY, Gin\u00e8s P, Schrier RW (1998) Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med 339:533\u2013541","journal-title":"N Engl J Med"},{"key":"2197_CR12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/qjmed\/hcm121","volume":"101","author":"Kashani","year":"2008","unstructured":"Kashani A, Landaverde C, Medici V, Rossaro L (2008) Fluid retention in cirrhosis: pathophysiology and management. QJM 101:71\u201385","journal-title":"QJM"},{"key":"2197_CR13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-2007-1007296","volume":"14","author":"Henriksen","year":"1994","unstructured":"Henriksen JH, Ring-Larsen H (1994) Hepatorenal disorders: role of the sympathetic nervous system. Semin Liver Dis 14:35\u201343","journal-title":"Semin Liver Dis"},{"key":"2197_CR14","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3748\/wjg.v12.i6.837","volume":"12","author":"Liu","year":"2006","unstructured":"Liu H, Gaskari SA, Lee SS (2006) Cardiac and vascular changes in cirrhosis: pathogenic mechanisms. World J Gastroenterol 12:837\u2013842","journal-title":"World J Gastroenterol"},{"key":"2197_CR15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","volume":"42","author":"Ruiz-del-Arbol","year":"2005","unstructured":"Ruiz-del-Arbol L, Monescillo A, Arocena C et al (2005) Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology 42:439\u2013447","journal-title":"Hepatology"},{"key":"2197_CR16","first-page":"F364","volume":"258","author":"Persson","year":"1990","unstructured":"Persson PB, Ehmke H, Nafz B, Kirchheim HR (1990) Sympathetic modulation of renal autoregulation by carotid occlusion in conscious dogs. Am J Physiol 258:F364\u2013F370","journal-title":"Am J Physiol"},{"key":"2197_CR17","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1440-1746.2002.02816.x","volume":"17","author":"Colle","year":"2002","unstructured":"Colle I, Durand F, Pessione F et al (2002) Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis. J Gastroenterol Hepatol 17:882\u2013888","journal-title":"J Gastroenterol Hepatol"},{"key":"2197_CR18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1055\/s-2007-1007129","volume":"19","author":"Wiest","year":"1999","unstructured":"Wiest R, Groszmann RJ (1999) Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance. Semin Liver Dis 19:411\u2013426","journal-title":"Semin Liver Dis"},{"key":"2197_CR19","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/gut.2010.236133","volume":"60","author":"Wong","year":"2011","unstructured":"Wong F, Nadim MK, Kellum JA et al (2011) Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut 60:702\u2013709","journal-title":"Gut"},{"key":"2197_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/j.ajkd.2007.05.008","volume":"50","author":"Levin","year":"2007","unstructured":"Levin A, Warnock DG, Mehta RL et al (2007) Improving outcomes from acute kidney injury: report of an initiative. Am J Kidney Dis 50:1\u20134","journal-title":"Am J Kidney Dis"},{"key":"2197_CR21","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","volume":"133","author":"Fern\u00e1ndez","year":"2007","unstructured":"Fern\u00e1ndez J, Navasa M, Planas R et al (2007) Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 133:818\u2013824","journal-title":"Gastroenterology"},{"key":"2197_CR22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","volume":"341","author":"Sort","year":"1999","unstructured":"Sort P, Navasa M, Arroyo V et al (1999) Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 341:403\u2013409","journal-title":"N Engl J Med"},{"key":"2197_CR23","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","volume":"119","author":"Akriviadis","year":"2000","unstructured":"Akriviadis E, Botla R, Briggs W et al (2000) Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 119:1637\u20131648","journal-title":"Gastroenterology"},{"key":"2197_CR24","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/hep.24786","volume":"55","author":"Bernardi","year":"2012","unstructured":"Bernardi M, Caraceni P, Navickis RJ, Wilkes MM (2012) Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. Hepatology 55:1172\u20131181","journal-title":"Hepatology"},{"key":"2197_CR25","first-page":"881","volume":"43","author":"Alessandria","year":"2011","unstructured":"Alessandria C, Elia C, Mezzabotta L et al (2011) Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study. Dig Liver Dis 43:881\u2013886","journal-title":"Dig Liver Dis"},{"key":"2197_CR26","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00007890-199102000-00030","volume":"51","author":"Gonwa","year":"1991","unstructured":"Gonwa TA, Morris CA, Goldstein RM et al (1991) Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome\u2013experience in 300 patients. Transplantation 51:428\u2013430","journal-title":"Transplantation"},{"key":"2197_CR27","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0140-6736(96)91667-0","volume":"347","author":"Soper","year":"1996","unstructured":"Soper CP, Latif AB, Bending MR (1996) Amelioration of hepatorenal syndrome with selective endothelin-A antagonist. Lancet 347:1842\u20131843","journal-title":"Lancet"},{"key":"2197_CR28","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0168-8278(05)80042-X","volume":"17","author":"Gin\u00e8s","year":"1993","unstructured":"Gin\u00e8s A, Salmer\u00f3n JM, Gin\u00e8s P et al (1993) Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure. J Hepatol 17:220\u2013226","journal-title":"J Hepatol"},{"key":"2197_CR29","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0016-5085(70)80066-X","volume":"58","author":"Barnardo","year":"1970","unstructured":"Barnardo DE, Baldus WP, Maher FT (1970) Effects of dopamine on renal function in patients with cirrhosis. Gastroenterology 58:524\u2013531","journal-title":"Gastroenterology"},{"key":"2197_CR30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep.510270107","volume":"27","author":"Guevara","year":"1998","unstructured":"Guevara M, Gin\u00e8s P, Fern\u00e1ndez-Esparrach G et al (1998) Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology 27:35\u201341","journal-title":"Hepatology"},{"key":"2197_CR31","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/MCG.0b013e318188947c","volume":"43","author":"Skagen","year":"2009","unstructured":"Skagen C, Einstein M, Lucey MR, Said A (2009) Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome. J Clin Gastroenterol 43:680\u2013685","journal-title":"J Clin Gastroenterol"},{"key":"2197_CR32","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/hep.510280407","volume":"28","author":"Angeli","year":"1998","unstructured":"Angeli P, Volpin R, Piovan D et al (1998) Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites. Hepatology 28:937\u2013943","journal-title":"Hepatology"},{"key":"2197_CR33","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2002.34343","volume":"36","author":"Duvoux","year":"2002","unstructured":"Duvoux C, Zanditenas D, H\u00e9zode C et al (2002) Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study. Hepatology 36:374\u2013380","journal-title":"Hepatology"},{"key":"2197_CR34","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/hep.23286","volume":"51","author":"Gluud","year":"2010","unstructured":"Gluud LL, Christensen K, Christensen E, Krag A (2010) Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome. Hepatology 51:576\u2013584","journal-title":"Hepatology"},{"key":"2197_CR35","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","volume":"47","author":"Brensing","year":"2000","unstructured":"Brensing KA, Textor J, Perz J et al (2000) Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 47:288\u2013295","journal-title":"Gut"},{"key":"2197_CR36","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/hep.510280219","volume":"28","author":"Guevara","year":"1998","unstructured":"Guevara M, Gin\u00e8s P, Bandi JC et al (1998) Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology 28:416\u2013422","journal-title":"Hepatology"},{"key":"2197_CR37","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/gut.2009.193227","volume":"59","author":"R\u00f6ssle","year":"2010","unstructured":"R\u00f6ssle M, Gerbes AL (2010) TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update. Gut 59:988\u20131000","journal-title":"Gut"},{"key":"2197_CR38","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1440-1746.2004.03471.x","volume":"19","author":"Witzke","year":"2004","unstructured":"Witzke O, Baumann M, Patschan D et al (2004) Which patients benefit from hemodialysis therapy in hepatorenal syndrome? J Gastroenterol Hepatol 19:1369\u20131373","journal-title":"J Gastroenterol Hepatol"},{"key":"2197_CR39","doi-asserted-by":"crossref","unstructured":"Capling RK, Bastani B (2004) The clinical course of patients with type 1 hepatorenal syndrome maintained on hemodialysis. Ren Fail 26, 563\u2013568","DOI":"10.1081\/JDI-200035988"},{"key":"2197_CR40","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ndt\/gfi212","volume":"21","author":"Marik","year":"2006","unstructured":"Marik PE, Wood K, Starzl TE (2006) The course of type 1 hepato-renal syndrome post liver transplantation. Nephrol Dial Transplant 21:478\u2013482","journal-title":"Nephrol Dial Transplant"},{"key":"2197_CR41","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1053\/jhep.2002.33160","volume":"35","author":"Nair","year":"2002","unstructured":"Nair S, Verma S, Thuluvath PJ (2002) Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 35:1179\u20131185","journal-title":"Hepatology"},{"key":"2197_CR42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-2008-1040323","volume":"28","author":"Arroyo","year":"2008","unstructured":"Arroyo V, Fernandez J, Gin\u00e8s P (2008) Pathogenesis and treatment of hepatorenal syndrome. Semin Liver Dis 28:81\u201395","journal-title":"Semin Liver Dis"}],"container-title":["Der Anaesthesist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-013-2197-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00101-013-2197-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-013-2197-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T21:28:52Z","timestamp":1563398932000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00101-013-2197-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["2197"],"URL":"https:\/\/doi.org\/10.1007\/s00101-013-2197-3","relation":{},"ISSN":["0003-2417","1432-055X"],"issn-type":[{"value":"0003-2417","type":"print"},{"value":"1432-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}